Please assess the completion status of the following clinical trial:

Trial Title: Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* confirmation of head \& neck cancer (stage I-IV) or non-small cell lung cancer (stage II \& III)~* Undergoing treatment with either radiation alone or in combination with chemotherapy~* Normal cognition and willingness to complete fatigue and quality of life forms, patient observation form, and pill diary~Exclusion Criteria:~* Hypersensitivity to dexamethasone or corticosteroids or Equal sugar substitute~* Corticosteroid within the past 30 days prior to study enrollment for greater than one week duration~* Planned Stereotactic Body Radiation Therapy (SBRT)~* Active psychosis~* Current pregnancy~* Active peptic ulcer disease or evidence of gastrointestinal bleed~* Current active tuberculosis or systemic fungal infection~* Previous diagnosis of diabetes mellitus~* Acute febrile illness~* Known human immunodeficiency virus or acquired immunodeficiency syndrome~* Major surgery within two weeks of study enrollment of which the patient has not recovered~* Psychostimulant use in the past 30 days prior to registration~* History of phenylketonuria (PKU)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 Placebo (Type: PLACEBO_COMPARATOR): Subjects receiving radiation therapy or radiation and chemotherapy randomly assigned to placebo bid for 14 days
- Arm 2 Dexamethasone (Type: ACTIVE_COMPARATOR): Subjects receiving radiation therapy or radiation and chemotherapy randomly assigned to dexamethasone 4 mg bid for 14 days

Based on this trial design, predict the completion outcome and termination type (if applicable).